secwatch.observer — SEC 8-K summary
======================================

Issuer:     Calidi Biotherapeutics, Inc. (CLDI)
CIK:        0001855485
Form:       8-K
Filed at:   2025-08-29T23:59:59+00:00
Accession:  0001641172-25-026066
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Calidi Bio posts updated corporate presentation; no specifics available
-----------------------------------------------------------------------

- Company made an updated presentation available on its website on August 29, 2025.
- Presentation content not included in filing; no material new facts disclosed.
- Investors should refer to the company's website for the actual presentation details.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855485/000164117225026066/0001641172-25-026066-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855485/000164117225026066/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-026066

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer